Characterization of triptolide hydroxylation by cytochrome P450 in human and rat liver microsomes

References

• Baranczewski P, Stanczak A, Sundberg K, Svensson R, Wallin A, Jansson J, Garberg P, Postlind H. Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacological Reports 2006; 58(4)453–472
   PubMed Web of Science ®Google Scholar
• Carter BZ, Mak DH, Schober WD, McQueen T, Harris D, Estrov Z, Evans RL, Andreeff M. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 2006; 108(2)630–637
   PubMed Web of Science ®Google Scholar
• Chen BJ. Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. leukemia and lymphoma 2001; 42(3)253–265
   PubMed Web of Science ®Google Scholar
• Fidler JM, Ku GY, Piazza D, Xu R, Jin R, Chen Z. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. III. Suppression of graft-versus-host disease in murine allogeneic bone marrow transplantation by the PG27 extract. Transplantation 2002; 74(4)445–457
   PubMed Web of Science ®Google Scholar
• Fidler JM, Li Y. Anticancer treatment using triptolide prodrugs. 2003, United States Patent No. 6620843
   Google Scholar
• Fidler JM, Li K, Chung C, Wei K, Ross JA, Gao M, Rosen GD. PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy. Molecular Cancer Therapeutics 2003; 2(9)855–862
   PubMed Web of Science ®Google Scholar
• Gu WZ, Chen R, Brandwein S, McAlpine J, Burres N. Isolation, purification, and characterization of immunosuppressive compounds from tripterygium: Triptolide and tripdiolide. International. Immunopharmacology 1995; 17(5)351–356
   PubMed Web of Science ®Google Scholar
• Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS Journal 2006; 8(1)E101–E111
   PubMed Web of Science ®Google Scholar
• Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology 1994; 47(9)1469–1479
   PubMed Web of Science ®Google Scholar
• Lasker JM, Wester MR, Aramsombatdee E, Raucy JL. Characterization of CYP2C19 and CYP2C9 from human liver: Respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Archives of Biochemistry and Biophysics 1998; 353(1)16–28
   PubMed Web of Science ®Google Scholar
• Lipsky PE, Fan ZS, Tao XLC, Gustafson KR, Hess S, Penzak SR. 2005, (available at: http://nidb.nih.gov/search/searchreport.taf?ipid=35102)
   Google Scholar
• Liu Y, Ma H, Zhang JW, Deng MC, Yang L. Influence of ginsenoside Rh1 and F1 on human cytochrome p450 enzymes. Planta Medica 2006a; 72(2)126–131
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang JW, Li W, Ma H, Sun J, Deng MC, Yang L. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes. Toxicological Sciences 2006b; 91(2)356–364
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 1951; 193(1)265–275
   PubMed Web of Science ®Google Scholar
• Ma J, Dey M, Yang H, Poulev A, Pouleva R, Dorn R, Lipsky PE, Kennelly EJ, Raskin I. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Phytochemistry 2007; 68(8)1172–1178
   PubMed Web of Science ®Google Scholar
• Matsui Y, Watanabe J, Ikegawa M, Kamoto T, Ogawa O, Nishiyama H. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Oncogene 2008; 27(33)4603–4614
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Terashita S, Kimura S, Suzuki A, Kagayama A, Sugiyama Y. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metabolism and Disposition 2001; 29(10)1316–1324
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2385
   PubMed Web of Science ®Google Scholar
• Ortiz de Montellano PR, Mathews JM. Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Isolation of an NN-bridged benzyne-protoporphyrin IX adduct. Biochemical Journal 1981; 195(3)761–764
   PubMed Web of Science ®Google Scholar
• Shao F, Wang G, Xie H, Zhu X, Sun J, A J. Pharmacokinetic study of triptolide, a constituent of immunosuppressive Chinese herb medicine, in rats. Biological and Pharmaceutical Bulletin 2007a; 30(4)702–707
   PubMed Web of Science ®Google Scholar
• Shao F, Wang GJ, Sun JG, Xie HT, Zhang R, Zhu XY. [Pharmacokinetics of triptolide in Beagle dogs]. Yao Xue Xue Bao 2007b; 42(1)61–65, [in Chinese]
   PubMedGoogle Scholar
• Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics 1994; 270(1)414–423
   PubMed Web of Science ®Google Scholar
• Tao X, Fan F, Hoffmann V, Gao CY, Longo NS, Zerfas P, Lipsky PE. Effective therapy for nephritis in (NZB × NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F. Arthritis and Rheumatism 2008; 58(6)1774–1783
   PubMed Web of Science ®Google Scholar
• Yang S, Chen J, Guo Z, Xu XM, Wang L, Pei XF, Yang J, Underhill CB, Zhang L. Triptolide inhibits the growth and metastasis of solid tumors. Molecular Cancer Therapeutics 2003; 2(1)65–72
   PubMed Web of Science ®Google Scholar
• Zhang JW, Ge GB, Liu Y, Wang LM, Liu XB, Zhang YY, Li W, He YQ, Wang ZT, Sun J, et al. Taxane's substituents at C3′ affect its regioselective metabolism: Different in vitro metabolism of cephalomannine and paclitaxel. Drug Metabolism and Disposition 2008; 36(2)418–426
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Cheng J, Li W, Ma H, Liu HT, Sun J, Wang LM, He YQ, Wang Y, et al. Inhibition of human liver cytochrome P450 by star fruit juice. Journal of Pharmacy and Pharmaceutical Sciences 2007; 10(4)496–503
   PubMed Web of Science ®Google Scholar
• Zhang JW, Liu Y, Li W, Hao DC, Yang L. Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes. European Journal of Clinical Pharmacology 2006; 62(7)497–502
   PubMed Web of Science ®Google Scholar
• Zheng J. [Screening of active anti-inflammatory, immunosuppressive and antifertility components of Tripterygium wilfordii. III. A comparison of the antiinflammatory and immunosuppressive activities of seven diterpene lactone epoxide compounds in vivo]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1991; 13(6)391–397, [in Chinese]
   PubMedGoogle Scholar